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Abstract
Objective—To develop a customized short LOS (<6 days) prediction model for geriatric patients
receiving cardiac surgery, using local data and a computational feature selection algorithm.
Design—Utilization of a machine learning algorithm in a prospectively collected STS database
consisting of patients who received cardiac surgery between January 2002 and June 2011.
Setting—Urban tertiary-care center.
Participants—Geriatric patients aged 70 years or older at the time of cardiac surgery.
Interventions—None.
Measurements and Main Results—Predefined morbidity and mortality events were collected
from the STS database. 23 clinically relevant predictors were investigated for short LOS
prediction with a genetic algorithm (GenAlg) in 1426 patients. Due to the absence of an STS
model for their particular surgery type, STS risk scores were unavailable for 771 patients. STS
prediction achieved an AUC of 0.629 while the GenAlg achieved AUCs of 0.573 (in those with
STS scores) and 0.691 (in those without STS scores). Among the patients with STS scores, the
GenAlg features significantly associated with shorter LOS were absence of congestive heart
failure (CHF) (OR = 0.59, p = 0.04), aortic valve procedure (OR = 1.54, p = 0.04), and shorter
cross clamp time (OR = 0.99, p = 0.004). In those without STS prediction, short LOS was
significantly correlated with younger age (OR = 0.93, p < 0.001), absence of CHF (OR = 0.53, p =
0.007), no preoperative use of beta blockers (OR = 0.66, p = 0.03), and shorter cross clamp time
(OR = 0.99, p < 0.001).
Conclusion—While the GenAlg-based models did not outperform STS prediction for patients
with STS risk scores, our local-data-driven approach reliably predicted short LOS for cardiac
surgery types that do not allow STS risk calculation. We advocate that each institution with
sufficient observational data should build their own cardiac surgery risk models.
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1. Introduction
With aging population, more and more geriatric patients with complex co-morbid conditions
at increased risk for morbidity and mortality present for cardiac surgery [1]. Risk scores
such as EuroSCORE [2] and the Society of Thoracic Surgeons (STS) risk score [3] are
commonly used to prognosticate the risk of postoperative morbidity and mortality. However,
these risk prediction models overestimate mortality risk, especially in high-risk and geriatric
patients [4], which might lead to denial of surgery for deserving patients. Furthermore, these
scores, having been derived from a large, heterogeneous population to optimize external
validity, tend to perform well at the population level but not as well at individual level. Such
sub-optimal predictive accuracy at the individual level could be attributed to the event
(mortality) rates in the 10% - 15% range [5]. This event rate range is challenging to predict
due to the computationally low prevalence but is clinically significant. In isolated aortic
valve replacement (AVR) in octogenarians, the actual mortality rates were as low as 5%
while the predicted rates by EuroSCORE and STS risk scores were three to four folds higher
[6].
Morbidity is more common than mortality and usually leads to increased postoperative
intensive care unit (ICU) length of stay (LOS) [7,8]. Increased postoperative ICU LOS leads
to higher costs and hence is a concern in the presence of ever shrinking health care funds
[9]. An accurate prediction of postoperative LOS allows better decision making, treatment
triaging and better allocation of resources. Models such as EuroSCORE, originally
constructed to assess mortality rates, have been subsequently used and validated for
prediction of prolonged ICU stay [8]. Several models derived from different populations
have attempted to predict prolonged ICU LOS. However, they had used different definitions
for prolonged stay and did not specifically focus on high risk geriatric patients and/or short
LOS stay [10-13]. Some scores such as STS cannot estimate risks for all patients undergoing
cardiac surgery, as they have been derived and validated only for specific subsets of surgery
such as coronary bypass grafting, valve surgery or a combination of both. As a result, the
STS risk models are unable to provide a score for other types or combinations of cardiac
surgery.
Therefore, there is a need for a patient-level risk prediction model for all patients undergoing
cardiac surgery, especially for those at a high risk such as geriatric patients. We
hypothesized that a local, custom built model derived from a more homogeneous subset of
patients would more accurately predict morbidity risk in geriatric populations, thus enabling
proactive decision making. In the present study, we employed a machine learning technique
called the genetic algorithm (GenAlg) to develop a customized model for short post-surgery
LOS prediction and compared its performance with that of the STS score.
2. Methods
2.1. Database
We performed a retrospective medical records review of geriatric patients who were aged 70
or older, and underwent elective cardiac surgery from January 2002 to June 2011 at an urban
tertiary-care center. We obtained approval from the Institutional Review Board of our
institution. We obtained the records from the Society of Thoracic Surgeons (STS) database
maintained by trained personnel at our institution since 2001. Two trained cardiac surgical
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tnurses report outcomes to the STS database in a quarterly fashion. They have periodic
internal checks and also receive reports from the Department of Public Health liaison on a
yearly basis commenting on data quality and necessary corrections. The database contains
all preoperative (e.g., demographic data, co-morbid conditions, inotropic support, STS risk
predictions for morbidity and mortality), intraoperative (e.g., cross clamp time), and
postoperative adverse outcomes (e.g., STS predefined morbid events such as stroke, atrial
fibrillation, renal failure, myocardial infarction, mortality, pulmonary morbidity, sternal
infection, and prolonged LOS).
The STS predefined morbid events include [3]:
• Operative mortality: death during the same hospitalization as surgery regardless of
timing, or within 30 days of surgery regardless of venue
• Permanent stroke (cerebrovascular accident): a central neurologic deficit persisting
longer than 72 hours
• Renal failure: a new requirement for dialysis or an increase in serum creatinine to
greater than 2.0 mg/dL and double the most recent preoperative creatinine level
• Prolonged ventilation: ventilation for more than 24 hours
• Deep sternal wound infection
• Reoperation for any reason
• Major morbidity or mortality: a composite defined as the occurrence of any of the
above end points
• Prolonged postoperative LOS: LOS greater than 14 days (alive or dead)
• Short postoperative LOS: LOS less than 6 days and patient discharged alive
2.2. Feature Pool
The following 22 preoperative features (predictors) were investigated for their predictive
power for short LOS (defined by STS as LOS < 6 days): age, gender, race, family history of
coronary artery disease (CAD), diabetes mellitus (DM), hypertension (HTN), chronic lung
disease, cerebrovascular disease (CVD), peripheral vascular disease (PVD), myocardial
infarction (MI), congestive heart failure (CHF), preoperative use of the following
medications: beta blockers, angiotensin converting enzyme inhibitors (ACEI), intravenous
(IV) nitrates, anticoagulants, inotropes, steroids, and aspirin; the type of cardiac surgery:
coronary artery bypass graft placement (CABG), aortic valve procedure, mitral valve
procedure, and last creatinine measurement prior to the surgery. In addition, one
intraoperative variable was added to the feature pool: cross clamp time. Hence, a total of 23
features were investigated.
2.3. Feature Selection and Evaluation
We applied a GenAlg [14] to computationally select features for prediction of short LOS.
GenAlgs are optimization routines that attempt to find a set of features that maximizes a
user-defined fitness function. In this study, the output of the fitness function was the area
under the receiver operating characteristic curve (AUC) of a logistic regression (LR) model
designed for short LOS prediction. Each combination of features was evaluated using the
fitness function, and the entire population of feature sets advanced to the next generation
with crossover and mutation in an attempt to “breed” fitter feature sets, which is analogous
to the process of biological evolution. The population size (number of feature combinations)
in this study was 1000. The entire data was randomly divided into 49% training, 21%
validation, and 30% test data. While the training data was used to build an LR model for a
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tgiven feature combination, the output of the fitness function was the predictive performance
(measured in AUC) of the LR model on the validation data. The final AUCs for the selected
features were computed based on the test data which had been held out prior to the
execution of the GenAlg and were the same across different numbers of features.
The GenAlg was executed separately for varying numbers of selected features: 5, 10, 15,
and 20. All features, 23 of them, were also evaluated without the GenAlg. Since GenAlg
performance depends on the initial population of randomly selected feature sets, the GenAlg
was repeated 5 times for each number of features. Among the 5 attempts, the feature
combination corresponding to the highest AUC based on the validation data was selected for
the final evaluation on the test data. Each GenAlg run was terminated after 50 generations.
STS prediction for short LOS was not available for all patients in our cohort. This is due to
the fact that STS does not have a prediction model for every type of cardiac surgery.
Therefore, the GenAlg was conducted independently on two sub-cohorts: the patients with
an STS short LOS prediction and those without. STS prediction served as the gold standard
in the sub-cohort where STS prediction was available, and STS AUC was computed on the
same test data on which the GenAlgselected features were evaluated.
Lastly, we built an LR model on all patients (without training, validation, and test partitions)
using the selected features in order to compute odds ratios (ORs) and the corresponding 95%
confidence intervals (CI). However, this analysis was still conducted separately for the two
sub-cohorts with and without STS prediction. Statistical significance was reached when p-
value was less than 0.05.
All feature selection and evaluation were conducted in MATLAB version R2010b
(Mathworks, Natick, MA, USA).
3. Results
1426 patients met the inclusion criteria and were analyzed. Table 1 summarizes the
characteristics of the patient cohort, stratified by availability of STS short LOS prediction.
There were slightly more patients without STS prediction than with. Short LOS accounted
for 44.1% and 31.1% of those with and without STS prediction, respectively. The patients
with STS prediction were slightly younger than those without, and the proportion of male
gender was higher among the patients with STS prediction than among those without.
Furthermore, the patients with STS prediction were generally in worse condition than those
without, which is supported by the higher prevalence of co-morbidities and preoperative
medication use. While an overwhelming majority of the patients with STS prediction
underwent CABG (possibly along with other procedures), the valve procedures were more
frequent among those without STS than those with.
Table 2 shows AUCs from test data associated with the features selected by the GenAlg.
STS prediction achieved an AUC of 0.629 on the same test data. Overall, our GenAlg
approach was unable to outperform STS for the patients with STS prediction. In general,
higher AUCs were achieved for the cases without STS prediction than for those with STS
prediction. Maximum AUCs of 0.573 and 0.691 were achieved with 15 and 10 features for
the sub-cohorts with and without STS prediction, respectively.
Table 3 lists the selected features, along with their ORs and 95% CIs, for the patients with
STS prediction. The features that were selected consistently across different numbers of
features were preoperative use of aspirin, aortic valve procedure, creatinine, and cross clamp
time. However, preoperative use of aspirin and creatinine never reached statistical
significance in any of the LR models. In the 15 feature model that resulted in the highest
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tAUC (see Table 2), short LOS was significantly correlated with absence of CHF (OR =
0.59, p = 0.04), aortic valve procedure (OR = 1.54, p = 0.04), and shorter cross clamp time
(OR = 0.99, p = 0.004).
Table 4 tabulates the counterpart information of Table 3 for the patients without STS
prediction. Age, preoperative use of IV nitrates, and perfusion time were consistently
selected by the GenAlg throughout the various numbers of features. Preoperative use of IV
nitrates was statistically insignificant in all models. As Table 2 showed, the 10 feature set
achieved the maximum AUC and revealed that short LOS was significantly correlated with
younger age (OR = 0.93, p < 0.001), absence of CHF (OR = 0.53, p = 0.007), no
preoperative use of beta blockers (OR = 0.66, p = 0.03), and shorter cross clamp time (OR =
0.99, p < 0.001).
4. Discussion
Our objective was to assess whether a custom model would more accurately predict
morbidity in comparison with the established STS model in our local geriatric population.
We utilized a GenAlg, an evolutionary algorithm that can perform automated feature
selection to maximize predictive performance. In addition to the preoperative variables
already utilized in the STS score, we also used intraoperative variables as these variables
also influence prognosis [15]. In the present study, the GenAlg-based model could not
outperform the STS score in those subjects with STS data. While the STS scores achieved
an AUC of 0.629 in those with STS prediction, our GenAlg-based model achieved a
maximum AUC of 0.573 in the subset with STS prediction and a maximum AUC of 0.691
in those without. Also, it is worthwhile noting that the GenAlg-based model consistently
achieved higher AUCs in those cases lacking an STS prediction than in those with STS
prediction. Hence, GenAlg-based modeling was shown to be useful for predicting shorter
LOS in geriatric patients for whom STS risk scores cannot be calculated. Furthermore, the
GenAlg-based model demonstrated better prediction utilizing fewer variables (10 to 15),
whereas the STS models use more than 30 variables. The significant association of shorter
cross clamp time with short LOS indicates the influence of intraoperative parameters on
postoperative course. It is important to note that intraoperative parameters are not part of the
STS scoring system [16].
Accurate prediction of prolonged post-cardiac-surgery LOS can be a crucial piece of
information for health care cost savings. The earlier clinicians and hospital administrators
are informed of potential excessive consumption of hospital resources, the better they can
allocate the limited resources they have. Moreover, keeping LOS at minimum is important
with respect to managing risk for hospital-acquired infections.
Building customized models rather than the traditional one-model-fits-all approach has been
shown to be meritorious in mortality prediction [17]. Such tailored clinical decision support
is now possible largely thanks to the advent of electronic health data that led to the
formation and maintenance of large local databases containing an enormous amount of
patient information. With respect to decision support driven by local health data, the
Institute of Medicine has recently elaborated on the need to start analyzing routinely
collected local data during patient care in order to improve care processes as well as clinical
outcomes [18].
In a systematic review and validation of prediction of prolonged LOS following cardiac
surgery, Ettema et al. [8] found that the Parsonnet score [19] (AUC of 0.75) and EuroScore
[20] (AUC of 0.71) were superior to the 20 models they chose to study. The focus in this
particular study was prolonged ICU LOS. ICU stay can be a nebulous definition as different
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tICUs have different criteria for ICU care. In addition, their definition of prolonged ICU LOS
was >48 hours of ICU stay. We chose to study hospital stay as an outcome and we focused
on prediction of shorter LOS following cardiac surgery in high risk geriatric patients only.
STS is limited to three risk models—CABG, Valve, and CABG + Valve [3,16]. These risk
models apply to seven types of surgery—CABG, aortic valve replacement (AVR), mitral
valve replacement (MVR), mitral valve repair (MV Repair), CABG + AVR, CABG + MVR,
and CABG + MV Repair. An STS risk score cannot be calculated for any procedure that
does not precisely fall into any of these categories. Also, age and gender are required
variables; no risk score can be calculated if either is not known. Our GenAlg approach
performed better at short LOS prediction among the patients without STS data compared to
those with. The model performance is based on the ability to discriminate between those
with and without short LOS and is expressed as an AUC. An AUC of 1 correlates with
perfect prediction and that of 0.5 translates to no predictive ability or leaving it to chance.
An AUC < 0.7 should be applied in clinical practice with caution. The GenAlg-based model
achieved a maximum AUC of 0.691 in those without STS prediction. The better
discriminating ability of our local model in those lacking STS risk scores points to the utility
of this model for such patients. Further studies are required to confirm this effect in similar
patient groups. The discriminative ability of a model not only depends on the model itself
but also on the dataset or population it is tested on [21]. One of the known weaknesses of
AUC is that it overestimates performance in a skewed data set. Furthermore, the larger
sample size of the sub-cohort without STS prediction could have been a factor in the
improved performance.
One area for future work is to validate our customized GenAlg-driven risk modeling
approach (rather than our specific models since they were customized for our institution) at
other institutions for external validity. Ultimately, an impact study will have to be conducted
to gauge the benefits of having accurate LOS prediction for cardiac patients with respect to
cost savings and reduction of hospital-acquired infections.
5. Conclusion
Our GenAlg-based models did not outperform STS prediction for patients with STS risk
scores. However, our customized approach based on local data reliably predicted short LOS
for cardiac surgery types that do not allow STS risk calculation. The primary strength of our
proposed risk stratification is its utilization of the most relevant data from a local data
repository rather than one-size-fits-all models. We advocate that each institution with
sufficient observational data should build their own risk models.
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Table 1
Patient cohort characteristics, stratified by availability of STS short LOS prediction.
STS prediction available STS prediction unavailable p-value2
Number of patients 655 771
Post-surgery LOS (days)1 6 [5, 8] 7 [5, 9] <0.001
Post-surgery LOS < 6 days 44.1% 31.1% <0.001
Age (years)1 76 [72, 80] 77 [73, 81] <0.001
Gender (male) 67.6% 54.0% <0.001
Race (non-Caucasian) 5.2% 4.3% 0.42
Family history of CAD 16.8% 14.9% 0.33
Diabetes mellitus 35.0% 25.0% <0.001
Hypertension 87.2% 83.5% 0.05
Chronic lung disease 9.5% 16.1% <0.001
CVD 17.4% 21.9% 0.03
PVD 17.7% 16.5% 0.54
MI 29.0% 19.7% <0.001
CHF 15.6% 23.7% <0.001
Preoperative use of beta blockers 76.8% 70.7% 0.009
Preoperative use of ACEI 47.3% 40.2% 0.007
Preoperative use of IV nitrates 3.4% 1.7% 0.04
Preoperative use of anticoagulants 20.0% 24.1% 0.06
Preoperative use of inotropes 0% 0.1% 0.36
Preoperative use of steroids 3.4% 4.3% 0.37
Preoperative use of aspirin 87.2% 70.9% <0.001
CABG 80.6% 43.3% <0.001
Aortic valve procedure 23.4% 54.3% <0.001
Mitral valve procedure 7.0% 25.3% <0.001
Last pre-surgery creatinine (mg/dL)1 1.0 [0.9, 1.2] 1 [0.8, 1.3] 0.88
Cross clamp time (min)1 63 [49, 75] 80 [63, 104] <0.001
LOS: length of stay, CAD: coronary artery disease, CVD: cerebrovascular disease, PVD: peripheral vascular disease, MI: myocardial infarction,
CHF: congestive heart failure, ACEI: angiotensin converting enzyme inhibitors, IV: intravenous, CABG: coronary artery bypass graft;
1
median [Q1, Q3],
2
calculated via the chi-squared test for binary variables and the Wilcoxon rank sum test for continuous variables.
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Table 2
Short LOS prediction AUC using the genetic algorithm and logistic regression. Different numbers of selected
features are shown for the two sub-cohorts: those with and without STS prediction. For comparison, the STS
prediction model achieved an AUC of 0.629 for the patients with calculated STS scores for short LOS.
Number of features STS prediction available STS prediction unavailable
5 0.545 0.681
10 0.563 0.691
15 0.573 0.676
20 0.551 0.672
23 (all features) 0.555 0.680
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Table 3
Features selected by the genetic algorithm for short LOS prediction among the patients who had STS
predictions available. For each number of features, only the selected ones are shown with OR and 95% CI.
The corresponding AUCs on test data are tabulated in Table 2.
Features
Number of features
5 10 15 20
Age (yr)
Gender (male) 1.00 (0.69 to 1.44) 1.07 (0.74 to 1.56)
Ethnicity (non-Caucasian) 1.03 (0.49 to 2.18) 1.02 (0.48 to 2.16)
Family history of CAD 0.95 (0.61 to 1.48)
Diabetes mellitus 1.02 (0.71 to 1.46)
Hypertension 0.67 (0.41 to 1.09) 0.71 (0.43 to 1.16)
Chronic lung disease 1.08 (0.61 to 1.93)
CVD 0.88 (0.56 to 1.39) 0.90 (0.57 to 1.43)
PVD 0.73 (0.47 to 1.15) 0.75 (0.47 to 1.19) 0.79 (0.49 to 1.26)
MI 0.79 (0.54 to 1.15) 0.88 (0.60 to 1.30)
CHF 0.59* (0.36 to 0.97) 0.57* (0.34 to 0.94)
Preoperative beta blockers 0.76 (0.51 to 1.13) 0.80 (0.53 to 1.21) 0.85 (0.56 to 1.30)
Preoperative ACEI 0.99 (0.71 to 1.38) 0.96 (0.68 to 1.35)
Preoperative IV nitrates 0.62 (0.23 to 1.67) 0.72 (0.27 to 1.94)
Preoperative anticoagulants 0.95 (0.61 to 1.47) 0.88 (0.56 to 1.40)
Preoperative inotropes 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Preoperative steroids 1.75 (0.68 to 4.48) 1.80 (0.70 to 4.64)
Preoperative aspirin 1.40 (0.85 to 2.30) 1.46 (0.88 to 2.42) 1.33 (0.80 to 2.21) 1.48 (0.88 to 2.51)
CABG 0.85 (0.50 to 1.45) 1.08 (0.55 to 2.15)
Aortic valve procedure 1.50* (1.00 to 2.24) 1.29 (0.78 to 2.13) 1.54* (1.02 to 2.33) 1.73 (0.91 to 3.30)
Mitral valve procedure 2.16 (0.90 to 5.18)
Creatinine (mg/dl) 0.80 (0.62 to 1.04) 0.82 (0.64 to 1.06) 0.83 (0.65 to 1.07) 0.84 (0.65 to 1.08)
Perfusion time (min) 0.99* (0.98 to 1.00) 0.99* (0.98 to 1.00) 0.99* (0.98 to 1.00) 0.99* (0.98 to 1.00)
OR: odds ratio, CI: confidence interval, CAD: coronary artery disease, CVD: cerebrovascular disease, PVD: peripheral vascular disease, MI:
myocardial infarction, CHF: congestive heart failure, ACEI: angiotensin converting enzyme inhibitors, IV: intravenous, CABG: coronary artery
bypass graft;
*
Statistically significant (p < 0.05).
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Table 4
Features selected by the genetic algorithm for short LOS prediction among the patients who did not have STS
predictions available. For each number of features, only the selected ones are shown with OR and 95% CI.
The corresponding AUCs on test data are tabulated in Table 2.
Features
Number of features
5 10 15 20
Age (yr) 0.93* (0.89 to 0.96) 0.93* (0.90 to 0.97) 0.93* (0.89 to 0.96) 0.94* (0.90 to 0.98)
Gender (male) 1.56* (1.05 to 2.32)
Ethnicity (non-Caucasian) 0.48 (0.15 to 1.51) 0.44 (0.13 to 1.44)
Family history of CAD 1.30 (0.81 to 2.10) 1.26 (0.77 to 2.04) 1.19 (0.73 to 1.95)
Diabetes mellitus 1.15 (0.74 to 1.78)
Hypertension 0.70 (0.43 to 1.13)
Chronic lung disease 1.07 (0.64 to 1.77) 1.04 (0.63 to 1.72) 1.16 (0.70 to 1.94)
CVD 0.69 (0.43 to 1.12)
PVD 0.75 (0.42 to 1.33)
MI 0.97 (0.60 to 1.57)
CHF 0.53* (0.33 to 0.84) 0.58* (0.36 to 0.94) 0.59* (0.37 to 0.97)
Preoperative beta blockers 0.66* (0.45 to 0.96) 0.65* (0.44 to 0.97)
Preoperative ACEI 1.36 (0.95 to 1.96) 1.41 (0.97 to 2.03) 1.43 (0.98 to 2.10)
Preoperative IV nitrates 0.27 (0.03 to 2.29) 0.36 (0.04 to 3.09) 0.33 (0.04 to 2.90) 0.32 (0.03 to 2.91)
Preoperative anticoagulants 1.07 (0.68 to 1.68) 1.00 (0.64 to 1.57)
Preoperative inotropes 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00) 1.00 (1.00 to 1.00)
Preoperative steroids 0.81 (0.26 to 2.56)
Preoperative aspirin 1.16 (0.78 to 1.71) 1.19 (0.79 to 1.80) 1.14 (0.75 to 1.73)
CABG 1.07 (0.70 to 1.63)
Aortic valve procedure 0.85 (0.53 to 1.37)
Mitral valve procedure 0.63* (0.41 to 0.95) 0.69 (0.45 to 1.06) 0.59* (0.34 to 1.00)
Creatinine (mg/dl) 0.91 (0.59 to 1.40) 0.82 (0.50 to 1.35)
Perfusion time (min) 0.99* (0.98 to 0.99) 0.99* (0.98 to 0.99) 0.99* (0.98 to 0.99) 0.99* (0.98 to 0.99)
OR: odds ratio, CI: confidence interval, CAD: coronary artery disease, CVD: cerebrovascular disease, PVD: peripheral vascular disease, MI:
myocardial infarction, CHF: congestive heart failure, ACEI: angiotensin converting enzyme inhibitors, IV: intravenous, CABG: coronary artery
bypass graft;
*
Statistically significant (p < 0.05).
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